APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurotensin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Neurotensin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025180 pages

Choose your research edition.

Industry ResearchNeurotensin Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurotensin Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Neurotensin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurotensin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurotensin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Neurotensin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Neurotensin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neurotensin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neurotensin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Neurotensin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neurotensin include APExBIO, Bio - Techne, Eurogentec, Genscript, MedChemExpress, Peptide Institute and PerkinElmer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Neurotensin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neurotensin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neurotensin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neurotensin market size, projected growth trends, production technologies, key applications, and end-use industries.

Neurotensin Segment by Company

APExBIO

Bio - Techne

Eurogentec

Genscript

MedChemExpress

Peptide Institute

PerkinElmer

Neurotensin Segment by Type

Bovine

Canine

Human

Mouse

Neurotensin Segment by Application

Scientific Research

Medical

Others

Neurotensin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurotensin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurotensin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurotensin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neurotensin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neurotensin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Neurotensin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Neurotensin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Neurotensin Industry Trends Table 2. Neurotensin Industry Drivers Table 3. Neurotensin Industry Opportunities and Challenges Table 4. Neurotensin Industry Restraints Table 5. Global Neurotensin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Neurotensin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Neurotensin Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Neurotensin Sales Market Share by Manufacturers Table 9. Global Neurotensin Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Neurotensin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Neurotensin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Neurotensin Manufacturers, Product Type & Application Table 13. Global Neurotensin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Neurotensin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Bovine Table 17. Major Manufacturers of Canine Table 18. Major Manufacturers of Human Table 19. Major Manufacturers of Mouse Table 20. Global Neurotensin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Neurotensin Sales by Type (2021-2026) & (K Units) Table 22. Global Neurotensin Sales by Type (2027-2032) & (K Units) Table 23. Global Neurotensin Sales Market Share by Type (2021-2026) Table 24. Global Neurotensin Sales Market Share by Type (2027-2032) Table 25. Global Neurotensin Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Neurotensin Revenue by Type (2021-2026) & (K Units) Table 27. Global Neurotensin Revenue by Type (2027-2032) & (K Units) Table 28. Global Neurotensin Revenue Market Share by Type (2021-2026) Table 29. Global Neurotensin Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Scientific Research Table 31. Major Manufacturers of Medical Table 32. Major Manufacturers of Others Table 33. Global Neurotensin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Neurotensin Sales by Application (2021-2026) & (K Units) Table 35. Global Neurotensin Sales by Application (2027-2032) & (K Units) Table 36. Global Neurotensin Sales Market Share by Application (2021-2026) Table 37. Global Neurotensin Sales Market Share by Application (2027-2032) Table 38. Global Neurotensin Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Neurotensin Revenue by Application (2021-2026) & (K Units) Table 40. Global Neurotensin Revenue by Application (2027-2032) & (K Units) Table 41. Global Neurotensin Revenue Market Share by Application (2021-2026) Table 42. Global Neurotensin Revenue Market Share by Application (2027-2032) Table 43. Global Neurotensin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Neurotensin Sales by Region (2021-2026) & (K Units) Table 45. Global Neurotensin Sales Market Share by Region (2021-2026) Table 46. Global Neurotensin Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Neurotensin Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Neurotensin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Neurotensin Sales by Country (2021-2026) & (K Units) Table 50. North America Neurotensin Sales by Country (2027-2032) & (K Units) Table 51. Europe Neurotensin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Neurotensin Sales by Country (2021-2026) & (K Units) Table 53. Europe Neurotensin Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Neurotensin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Neurotensin Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Neurotensin Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Neurotensin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Neurotensin Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Neurotensin Sales by Country (2027-2032) & (K Units) Table 60. Global Neurotensin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Neurotensin Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Neurotensin Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Neurotensin Revenue Market Share by Region (2021-2026) Table 64. Global Neurotensin Revenue Market Share by Region (2027-2032) Table 65. APExBIO Company Information Table 66. APExBIO Business Overview Table 67. APExBIO Neurotensin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. APExBIO Neurotensin Product Portfolio Table 69. APExBIO Recent Development Table 70. Bio - Techne Company Information Table 71. Bio - Techne Business Overview Table 72. Bio - Techne Neurotensin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Bio - Techne Neurotensin Product Portfolio Table 74. Bio - Techne Recent Development Table 75. Eurogentec Company Information Table 76. Eurogentec Business Overview Table 77. Eurogentec Neurotensin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Eurogentec Neurotensin Product Portfolio Table 79. Eurogentec Recent Development Table 80. Genscript Company Information Table 81. Genscript Business Overview Table 82. Genscript Neurotensin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Genscript Neurotensin Product Portfolio Table 84. Genscript Recent Development Table 85. MedChemExpress Company Information Table 86. MedChemExpress Business Overview Table 87. MedChemExpress Neurotensin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. MedChemExpress Neurotensin Product Portfolio Table 89. MedChemExpress Recent Development Table 90. Peptide Institute Company Information Table 91. Peptide Institute Business Overview Table 92. Peptide Institute Neurotensin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Peptide Institute Neurotensin Product Portfolio Table 94. Peptide Institute Recent Development Table 95. PerkinElmer Company Information Table 96. PerkinElmer Business Overview Table 97. PerkinElmer Neurotensin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. PerkinElmer Neurotensin Product Portfolio Table 99. PerkinElmer Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Neurotensin Distributors List Table 103. Neurotensin Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Neurotensin Product Image Figure 2. Global Neurotensin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurotensin Market Size (2021-2032) & (US$ Million) Figure 4. Global Neurotensin Sales (2021-2032) & (K Units) Figure 5. Global Neurotensin Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Neurotensin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Bovine Image Figure 9. Canine Image Figure 10. Human Image Figure 11. Mouse Image Figure 12. Global Neurotensin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Neurotensin Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Neurotensin Sales Market Share by Type (2021-2032) Figure 15. Global Neurotensin Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Neurotensin Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Neurotensin Revenue Market Share by Type (2021-2032) Figure 18. Scientific Research Image Figure 19. Medical Image Figure 20. Others Image Figure 21. Global Neurotensin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Neurotensin Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Neurotensin Sales Market Share by Application (2021-2032) Figure 24. Global Neurotensin Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Neurotensin Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Neurotensin Revenue Market Share by Application (2021-2032) Figure 27. North America Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Neurotensin Sales Market Share by Country (2021-2032) Figure 29. U.S. Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Neurotensin Sales Market Share by Country (2021-2032) Figure 34. Germany Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Neurotensin Sales Market Share by Country (2021-2032) Figure 41. China Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Neurotensin Sales Market Share by Country (2021-2032) Figure 49. Brazil Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Neurotensin Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Neurotensin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Neurotensin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Neurotensin Revenue (2021-2032) & (US$ Million) Figure 60. North America Neurotensin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Neurotensin Revenue (2021-2032) & (US$ Million) Figure 62. Europe Neurotensin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Neurotensin Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Neurotensin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Neurotensin Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Neurotensin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Neurotensin Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Neurotensin Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Bovine
  • Canine
  • Human
  • Mouse
Applications
  • Scientific Research
  • Medical
  • Others
Companies covered
  • APExBIO
  • Bio - Techne
  • Eurogentec
  • Genscript
  • MedChemExpress
  • Peptide Institute
  • PerkinElmer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neurotensin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neurotensin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Neurotensin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Neurotensin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Neurotensin Market Dynamics
  1. 2.1 Neurotensin Industry Trends
  2. 2.2 Neurotensin Industry Drivers
  3. 2.3 Neurotensin Industry Opportunities and Challenges
  4. 2.4 Neurotensin Industry Restraints
3 Neurotensin Market by Manufacturers
  1. 3.1 Global Neurotensin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Neurotensin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Neurotensin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Neurotensin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neurotensin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Neurotensin Manufacturers, Product Type & Application
  7. 3.7 Global Neurotensin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neurotensin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neurotensin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neurotensin Tier 1, Tier 2, and Tier 3
4 Neurotensin Market by Type
  1. 4.1 Neurotensin Type Introduction
  2. 4.1.1 Bovine
  3. 4.1.2 Canine
  4. 4.1.3 Human
  5. 4.1.4 Mouse
  6. 4.2 Global Neurotensin Sales by Type
  7. 4.2.1 Global Neurotensin Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Neurotensin Sales by Type (2021-2032)
  9. 4.2.3 Global Neurotensin Sales Market Share by Type (2021-2032)
  10. 4.3 Global Neurotensin Revenue by Type
  11. 4.3.1 Global Neurotensin Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Neurotensin Revenue by Type (2021-2032)
  13. 4.3.3 Global Neurotensin Revenue Market Share by Type (2021-2032)
5 Neurotensin Market by Application
  1. 5.1 Neurotensin Application Introduction
  2. 5.1.1 Scientific Research
  3. 5.1.2 Medical
  4. 5.1.3 Others
  5. 5.2 Global Neurotensin Sales by Application
  6. 5.2.1 Global Neurotensin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neurotensin Sales by Application (2021-2032)
  8. 5.2.3 Global Neurotensin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Neurotensin Revenue by Application
  10. 5.3.1 Global Neurotensin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Neurotensin Revenue by Application (2021-2032)
  12. 5.3.3 Global Neurotensin Revenue Market Share by Application (2021-2032)
6 Global Neurotensin Sales by Region
  1. 6.1 Global Neurotensin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neurotensin Sales by Region (2021-2032)
  3. 6.2.1 Global Neurotensin Sales by Region (2021-2026)
  4. 6.2.2 Global Neurotensin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neurotensin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Neurotensin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Neurotensin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Neurotensin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Neurotensin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Neurotensin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Neurotensin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Neurotensin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Neurotensin Revenue by Region
  1. 7.1 Global Neurotensin Revenue by Region
  2. 7.1.1 Global Neurotensin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Neurotensin Revenue by Region (2021-2026)
  4. 7.1.3 Global Neurotensin Revenue by Region (2027-2032)
  5. 7.1.4 Global Neurotensin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Neurotensin Revenue (2021-2032)
  8. 7.2.2 North America Neurotensin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Neurotensin Revenue (2021-2032)
  11. 7.3.2 Europe Neurotensin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Neurotensin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Neurotensin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Neurotensin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Neurotensin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 APExBIO
  2. 8.1.1 APExBIO Company Information
  3. 8.1.2 APExBIO Business Overview
  4. 8.1.3 APExBIO Neurotensin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 APExBIO Neurotensin Product Portfolio
  6. 8.1.5 APExBIO Recent Developments
  7. 8.2 Bio - Techne
  8. 8.2.1 Bio - Techne Company Information
  9. 8.2.2 Bio - Techne Business Overview
  10. 8.2.3 Bio - Techne Neurotensin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bio - Techne Neurotensin Product Portfolio
  12. 8.2.5 Bio - Techne Recent Developments
  13. 8.3 Eurogentec
  14. 8.3.1 Eurogentec Company Information
  15. 8.3.2 Eurogentec Business Overview
  16. 8.3.3 Eurogentec Neurotensin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eurogentec Neurotensin Product Portfolio
  18. 8.3.5 Eurogentec Recent Developments
  19. 8.4 Genscript
  20. 8.4.1 Genscript Company Information
  21. 8.4.2 Genscript Business Overview
  22. 8.4.3 Genscript Neurotensin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Genscript Neurotensin Product Portfolio
  24. 8.4.5 Genscript Recent Developments
  25. 8.5 MedChemExpress
  26. 8.5.1 MedChemExpress Company Information
  27. 8.5.2 MedChemExpress Business Overview
  28. 8.5.3 MedChemExpress Neurotensin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MedChemExpress Neurotensin Product Portfolio
  30. 8.5.5 MedChemExpress Recent Developments
  31. 8.6 Peptide Institute
  32. 8.6.1 Peptide Institute Company Information
  33. 8.6.2 Peptide Institute Business Overview
  34. 8.6.3 Peptide Institute Neurotensin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Peptide Institute Neurotensin Product Portfolio
  36. 8.6.5 Peptide Institute Recent Developments
  37. 8.7 PerkinElmer
  38. 8.7.1 PerkinElmer Company Information
  39. 8.7.2 PerkinElmer Business Overview
  40. 8.7.3 PerkinElmer Neurotensin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 PerkinElmer Neurotensin Product Portfolio
  42. 8.7.5 PerkinElmer Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neurotensin Value Chain Analysis
  2. 9.1.1 Neurotensin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neurotensin Production Mode & Process
  6. 9.2 Neurotensin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neurotensin Distributors
  9. 9.2.3 Neurotensin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst